Skip to content
Screener

Price / book at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
1.7×0.0×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
316.5×+303×
RFL
Rafael Holdings, Inc.RFL
0.9×+0.1×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
1.2×-16.1×
XER
Xeris Biopharma Holdings, Inc.XERS
76.9×
Theravance Biopharma logo
Theravance BiopharmaTBPH
2.9×+0.2×

Other financials

Income statement

See full
Revenue$39.7M+53.3%
Gross profit$38.1M+182%
Operating income$16.8M+124%
Net income$8.8M-88.3%
EPS (diluted)$0.14-88.4%

Balance sheet

See full
Cash & equivalents$145.3M+205%
Total debt$1.5M-97.6%
Total equity$217.7M+85.7%
Total assets$302.7M+18.1%

Cash flow

See full
Operating cash flow$17.0M+573%
CapEx$217.0K+1.9%
Free cash flow$16.8M+541%

Valuation

See full
Market cap$705.48M+12.4%
Enterprise value$561.65M-12.6%
P/E12.1×-225×
P/S5.2×-4.9×

Profitability

See full
Gross margin95.5%+23.5pp
Operating margin-103.9%-43.0pp
Net margin42.8%+38.6pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity34.8%+31.3pp
Debt / equity-0.5×
Current ratio5.2×-2.7×

Where this comes from

Calculated from Zevra Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001434647-26-000068

FAQ

What is Zevra Therapeutics, Inc.'s price / book?
Zevra Therapeutics, Inc. (ZVRA) reported price / book of 3.9× in Q2 2026.
How has Zevra Therapeutics, Inc.'s price / book changed year-over-year?
Zevra Therapeutics, Inc.'s price / book decreased by 8.7% year-over-year, from 4.3× to 3.9×.
What is the long-term trend for Zevra Therapeutics, Inc.'s price / book?
Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s price / book has grown at a 1.9% compound annual growth rate (CAGR), from 3× to 3.3×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Zevra Therapeutics, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude